Mitochondrial Enhancement for Neurodegenerative Movement Disorders: A Systematic Review of Trials Involving Creatine, Coenzyme Q10, Idebenone and Mitoquinone

8OHdG is not a biomarker for Huntington disease state or progression

(2013) B. Borowsky et al.   NEUROLOGY

Mutations in COQ2 in Familial and Sporadic Multiple-System Atrophy

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Creatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers

(2012) Olivier Braissant   JOURNAL OF INHERITED METABOLIC DISEASE

Coenzyme Q10 deficiency in patients with Parkinson's disease

(2012) Laurie K. Mischley et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

The effects of idebenone on mitochondrial bioenergetics

(2011) Valentina Giorgio et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS

Idebenone Induces Apoptotic Cell Death in the Human Dopaminergic Neuroblastoma SHSY-5Y Cells

(2011) Kwok-Keung Tai et al.   NEUROTOXICITY RESEARCH

Mitochondrial Approaches for Neuroprotection

(2010) Rajnish K. Chaturvedi et al.   Annals of the New York Academy of Sciences

A Phase 3, Double-blind, Placebo-Controlled Trial of Idebenone in Friedreich Ataxia

(2010) David R. Lynch et al.   ARCHIVES OF NEUROLOGY

A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease

(2010) Barry J. Snow et al.   MOVEMENT DISORDERS

Pharmacotherapy for Friedreich Ataxia

(2009) Amy Y. Tsou et al.   CNS DRUGS

Short-term effects of coenzyme Q10 in progressive supranuclear palsy: A randomized, placebo-controlled trial

(2008) Maria Stamelou et al.   MOVEMENT DISORDERS